Pages that link to "Q34046760"
Jump to navigation
Jump to search
The following pages link to Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures (Q34046760):
Displaying 9 items.
- Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance (Q39269008) (← links)
- Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress. (Q41717569) (← links)
- A resurging boom in new drugs for epilepsy and brain disorders. (Q48093388) (← links)
- Neonatal Seizure Models to Study Epileptogenesis. (Q55263376) (← links)
- Effects of combined brief etomidate anesthesia and postnatal stress on amygdala expression of Cl cotransporters and corticotropin-releasing hormone and alcohol intake in adult rats (Q57465294) (← links)
- The Pharmacological Assessment of GABA Receptor Activation in Experimental Febrile Seizures in Mice (Q64067309) (← links)
- Pharmaco-resistant Neonatal Seizures: Critical Mechanistic Insights from a Chemoconvulsant Model (Q91095612) (← links)
- Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP (Q92290189) (← links)
- Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders (Q98578234) (← links)